PEGylated PLGA Nanoformulations For Effective Immunomodulatory Actors In Non-Small Cell Lung Cancer. [PDF]
Huang M, Zhang J, Hao Z, Wang Q, Liu W.
europepmc +1 more source
The role of miRNA-32 in non-small cell lung cancer. [PDF]
Ding D, Hong H, Shi K.
europepmc +1 more source
SnapShot: Non-Small Cell Lung Cancer
Heist, Rebecca S., Engelman, Jeffrey A.
openaire +2 more sources
ZUP1 contributes to cisplatin resistance and treg-related signaling in non-small cell lung cancer. [PDF]
Xiong W +6 more
europepmc +1 more source
Multilevel Network Meta-Regression With a Survival Outcome and an Application to Non-Small Cell Lung Cancer. [PDF]
Jia R +5 more
europepmc +1 more source
Cancer Vaccine Strategies in Non-Small Cell Lung Cancer. [PDF]
Velasco RN +4 more
europepmc +1 more source
Therapeutic inhibition of RAS in non-small cell lung cancer. [PDF]
Nichols KB, Herzberg BO.
europepmc +1 more source
Advanced non-small cell lung cancer with SMARCA4 deficiency: a case report. [PDF]
Chai J +7 more
europepmc +1 more source
Economic value and clinical role of minimally invasive, biopsy-based diagnostics in non-small cell lung cancer. [PDF]
Guo J +4 more
europepmc +1 more source
Adjuvant Nivolumab vs Observation in Resected Non-Small Cell Lung Cancer: A Randomized Clinical Trial. [PDF]
Chaft JE +28 more
europepmc +1 more source

